Pour voir les autres types de publications sur ce sujet consultez le lien suivant : PASH syndrome.

Articles de revues sur le sujet « PASH syndrome »

Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres

Choisissez une source :

Consultez les 50 meilleurs articles de revues pour votre recherche sur le sujet « PASH syndrome ».

À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.

Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.

Parcourez les articles de revues sur diverses disciplines et organisez correctement votre bibliographie.

1

Sai Lahari, R., R. Uday Kiran, M. Hemalatha, and A. Vijaya Mohan Rao. "PASH SYNDROME CO-EXISTING WITH RHEUMATIC HEART DISEASE AND SEVERE MITRAL VALVE REGURGITATION: A RARE CASE REPORT." International Journal of Advanced Research 11, no. 01 (2023): 239–41. http://dx.doi.org/10.21474/ijar01/16012.

Texte intégral
Résumé :
Pyoderma gangrenosum, Acne, and Hidradenitis Suppurativa (PASH) is a rare inflammatory syndrome, the exact etiology and pathogenesis of which remains unknown. PASH syndrome belongs to the spectrum of Interleukin-1 driven auto-inflammatory diseases.InPatientsdiagnosed with PASH syndrome, various ways of treatment are available with individual differences in efficacy. We reporta new case of PASH syndrome that highlights the features of this rare condition and is coexisting with rheumatic heart disease and severe mitral valve regurgitation.
Styles APA, Harvard, Vancouver, ISO, etc.
2

Chaoui, Rhizlane, Zakia Douhi, and Selma El Kadiri. "A case of PASH syndrome." Our Dermatology Online 11, e (2020): e60.1-e60.2. http://dx.doi.org/10.7241/ourd.2020e.60.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
3

Gracia-Cazaña, Tamara, María Frias, Rosa Roselló, Jesús Vera-Álvarez, and Yolanda Gilaberte. "PASH syndrome associated with osteopoikilosis." International Journal of Dermatology 54, no. 9 (2015): e369-e371. http://dx.doi.org/10.1111/ijd.12827.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
4

McCarthy, S., C. C. Foley, V. Dvorakova, C. Quinlan, M. Murphy, and M. Maher. "PASH syndrome with bony destruction." Clinical and Experimental Dermatology 44, no. 8 (2019): 918–20. http://dx.doi.org/10.1111/ced.13909.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
5

Cawen, Irina, Jorge Navarrete, and Caroline Agorio. "PASH syndrome: a novel surgical approach." Anais Brasileiros de Dermatologia 97, no. 1 (2022): 121–23. http://dx.doi.org/10.1016/j.abd.2020.08.034.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
6

Zhang, Xiaofeng, Yanyan He, Haoxiang Xu, and Baoxi Wang. "First PSENEN mutation in PASH syndrome." Journal of Dermatology 47, no. 11 (2020): 1335–37. http://dx.doi.org/10.1111/1346-8138.15527.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
7

Brochet, T., C. Joachim-Naepels, A. Dadban, et al. "Un cas de syndrome PASH traité par sécukinumab." Annales de Dermatologie et de Vénéréologie - FMC 2, no. 8 (2022): A243. http://dx.doi.org/10.1016/j.fander.2022.10.059.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
8

Gönül, Müzeyyen, Bengu Cevirgen Cemil, Havva Ozge Keseroglu, and Havva Kaya Akis. "New Described Dermatological Disorders." BioMed Research International 2014 (2014): 1–13. http://dx.doi.org/10.1155/2014/616973.

Texte intégral
Résumé :
Many advances in dermatology have been made in recent years. In the present review article, newly described disorders from the last six years are presented in detail. We divided these reports into different sections, including syndromes, autoinflammatory diseases, tumors, and unclassified disease. Syndromes included are “circumferential skin creases Kunze type” and “unusual type of pachyonychia congenita or a new syndrome”; autoinflammatory diseases include “chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome,” “pyoderma gangrenosum, acne, and
Styles APA, Harvard, Vancouver, ISO, etc.
9

Gul, Muhammad, Vivek Singam, Cody Hanson, Brett Neill, Daniel Aires, and Anand Rajpara. "Remission of Refractory PASH Syndrome Using Ixekizumab and Doxycycline." Journal of Drugs in Dermatology 19, no. 11 (2020): 1124–25. http://dx.doi.org/10.36849/jdd.2020.1123.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
10

Baroud, Sumer, Jim Wu, and Christos C. Zouboulis. "Acne Syndromes and Mosaicism." Biomedicines 9, no. 11 (2021): 1735. http://dx.doi.org/10.3390/biomedicines9111735.

Texte intégral
Résumé :
Abnormal mosaicism is the coexistence of cells with at least two genotypes, by the time of birth, in an individual derived from a single zygote, which leads to a disease phenotype. Somatic mosaicism can be further categorized into segmental mosaicism and nonsegmental somatic mosaicism. Acne is a chronic illness characterized by inflammatory changes around and in the pilosebaceous units, commonly due to hormone- and inflammatory signaling-mediated factors. Several systemic disorders, such as congenital adrenal hyperplasia, polycystic ovarian syndrome, and seborrhoea-acne-hirsutism-androgenetic
Styles APA, Harvard, Vancouver, ISO, etc.
11

Lamiaux, M. C., F. Dabouz, M. Wantz, D. Lebas, D. Courivaud, and P. Modiano. "PASH syndrome : efficacité rifampicine-clindamycine sur un pyoderma gangrenosum résistant." Annales de Dermatologie et de Vénéréologie 143, no. 12 (2016): S250. http://dx.doi.org/10.1016/j.annder.2016.09.345.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
12

Devergne, C., P. Schoenlaub, and A. Saraux. "Efficacité des inhibiteurs de l’interleukine 17 dans le syndrome PASH." Annales de Dermatologie et de Vénéréologie 146, no. 12 (2019): A212. http://dx.doi.org/10.1016/j.annder.2019.09.317.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
13

Staub, J., N. Pfannschmidt, R. Strohal, et al. "Successful treatment of PASH syndrome with infliximab, cyclosporine and dapsone." Journal of the European Academy of Dermatology and Venereology 29, no. 11 (2014): 2243–47. http://dx.doi.org/10.1111/jdv.12765.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
14

Wargo, Jeffrey J., and Brian T. Emmer. "Systemic Inflammation Gone Awry: PASH Syndrome and Temporomandibular Joint Ankylosis." American Journal of Medicine 129, no. 4 (2016): e1-e3. http://dx.doi.org/10.1016/j.amjmed.2015.12.019.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
15

Niv, Dorene, James A. Ramirez, and David P. Fivenson. "Pyoderma gangrenosum, acne, and hidradenitis suppurativa (PASH) syndrome with recurrent vasculitis." JAAD Case Reports 3, no. 1 (2017): 70–73. http://dx.doi.org/10.1016/j.jdcr.2016.11.006.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
16

Braun-Falco, Markus, Oleksandr Kovnerystyy, Peter Lohse, and Thomas Ruzicka. "Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)?a new autoinflammatory syndrome distinct from PAPA syndrome." Journal of the American Academy of Dermatology 66, no. 3 (2012): 409–15. http://dx.doi.org/10.1016/j.jaad.2010.12.025.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
17

Nedelcu, Roxana Ioana. "PASH Syndrome: Comparing Pathogenic Mechanism of Pyoderma Gangrenosum, Acne and Suppurative Hidradenitis." American Journal of Biomedical Science & Research 11, no. 1 (2020): 64–70. http://dx.doi.org/10.34297/ajbsr.2020.11.001587.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
18

Duchatelet, S., S. Miskinyte, O. Join‐Lambert, et al. "First nicastrin mutation in PASH (pyoderma gangrenosum, acne and suppurative hidradenitis) syndrome." British Journal of Dermatology 173, no. 2 (2015): 610–12. http://dx.doi.org/10.1111/bjd.13668.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
19

Faffa, M. S., C. Paul, I. Touitou, and L. Misery. "Une nouvelle entité : le PASH syndrome (pyoderma gangrenosum, acné et hidradénite suppurée)." Annales de Dermatologie et de Vénéréologie 141, no. 12 (2014): S430—S431. http://dx.doi.org/10.1016/j.annder.2014.09.455.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
20

LI, CHENGRANG, HAOXIANG XU, and BAOXI WANG. "Is SAPHO Syndrome Linked to PASH Syndrome and Hidradenitis Suppurativa by Nicastrin Mutation? A Case Report." Journal of Rheumatology 45, no. 11 (2018): 1605.3–1607. http://dx.doi.org/10.3899/jrheum.171007.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
21

Ursani, Mohammad A., Joan Appleyard, and Onome Whiteru. "Pyogenic Arthritis, Pyoderma Gangrenosum, Acne, Suppurative Hidradenitis (PA-PASH) Syndrome: An Atypical Presentation of a Rare Syndrome." American Journal of Case Reports 17 (August 17, 2016): 587–91. http://dx.doi.org/10.12659/ajcr.898027.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
22

Zagaria, Orlando, Angelo Ruggiero, Gabriella Fabbrocini, Lucia Gallo, Marco Romanelli, and Claudio Marasca. "Wound care, adalimumab, and multidisciplinary approach in a patient affected by PASH syndrome." International Wound Journal 17, no. 5 (2020): 1528–31. http://dx.doi.org/10.1111/iwj.13403.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
23

Calderón‐Castrat, X., D. Bancalari‐Díaz, C. Román‐Curto, et al. "PSTPIP 1 gene mutation in a pyoderma gangrenosum, acne and suppurative hidradenitis ( PASH ) syndrome." British Journal of Dermatology 175, no. 1 (2016): 194–98. http://dx.doi.org/10.1111/bjd.14383.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
24

Zivanovic, Dubravka, Iva Masirevic, Thomas Ruzicka, Markus Braun-Falco, and Milos Nikolic. "Pyoderma gangrenosum, acne, suppurative hidradenitis (PASH) and polycystic ovary syndrome: Coincidentally or aetiologically connected?" Australasian Journal of Dermatology 58, no. 2 (2016): e54-e59. http://dx.doi.org/10.1111/ajd.12438.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
25

Chasset, F., C. Demongeot, R. Jonathan, et al. "Acné nodulaire, pyoderma gangrenosum et hidrosadénite suppurée (syndrome PASH) satellites d’une maladie de Crohn." Annales de Dermatologie et de Vénéréologie 140, no. 12 (2013): S558. http://dx.doi.org/10.1016/j.annder.2013.09.442.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
26

Parisi, Paola, Federica Vinci, Filippo Di Meglio, et al. "Recurrent Extreme Bilateral Gigantomastia Caused by Pseudoangiomatous Stromal Hyperplasia (PASH) Syndrome: A Case Report." Plastic and Reconstructive Surgery - Global Open 11, no. 1 (2023): e4571. http://dx.doi.org/10.1097/gox.0000000000004571.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
27

Nikolakis, Georgios, Katja Kreibich, Aristeidis Vaiopoulos, et al. "Case Report: PsAPSASH syndrome: an alternative phenotype of syndromic hidradenitis suppurativa treated with the IL-17A inhibitor secukinumab." F1000Research 10 (May 13, 2021): 381. http://dx.doi.org/10.12688/f1000research.52100.1.

Texte intégral
Résumé :
Syndromic hidradenitis suppurativa (HS) is a form of symptom constellations, which differs from the familial and genetic form and comprises predominantly osteoarticular manifestations. Many forms include pyoderma gangrenosum and acne (PASH), pyogenic arthritis (PAPASH), spondyloarthritis (PASS) and psoriatic arthritis (PsaPASH) and are categorized in the autoinflammatory syndromes. anti-TNF-α and anti-IL-1a blockade are between the therapeutic approaches that improve skin symptoms and prevent permanent osteoarticular damage. This case report refers to the successful treatment of a mixed phenot
Styles APA, Harvard, Vancouver, ISO, etc.
28

Nikolakis, Georgios, Katja Kreibich, Aristeidis Vaiopoulos, et al. "Case Report: PsAPSASH syndrome: an alternative phenotype of syndromic hidradenitis suppurativa treated with the IL-17A inhibitor secukinumab." F1000Research 10 (July 16, 2021): 381. http://dx.doi.org/10.12688/f1000research.52100.2.

Texte intégral
Résumé :
Syndromic hidradenitis suppurativa (HS) is a form of symptom constellations, which differs from the familial and genetic form and comprises predominantly osteoarticular manifestations. Many forms include pyoderma gangrenosum and acne (PASH), pyogenic arthritis (PAPASH), spondyloarthritis (PASS) and psoriatic arthritis (PsAPASH) and are categorized in the autoinflammatory syndromes. Anti-TNF-α and anti-IL-1a blockade are between the therapeutic approaches that improve skin symptoms and prevent permanent osteoarticular damage. This case report refers to the successful treatment of a mixed phenot
Styles APA, Harvard, Vancouver, ISO, etc.
29

Lamiaux, Marie, Fadia Dabouz, Maud Wantz, et al. "Successful combined antibiotic therapy with oral clindamycin and oral rifampicin for pyoderma gangrenosum in patient with PASH syndrome." JAAD Case Reports 4, no. 1 (2018): 17–21. http://dx.doi.org/10.1016/j.jdcr.2017.05.005.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
30

Uitto, J., M. Faraji Zonooz, F. Sabbagh-Kermani, et al. "159 PASH syndrome is not a genetically distinct entity but belongs to the spectrum of autoinflammatory skin phenotypes." Journal of Investigative Dermatology 136, no. 9 (2016): S188. http://dx.doi.org/10.1016/j.jid.2016.06.177.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
31

Join-Lambert, Olivier, Sabine Duchatelet, Maïa Delage, et al. "Remission of refractory pyoderma gangrenosum, severe acne, and hidradenitis suppurativa (PASH) syndrome using targeted antibiotic therapy in 4 patients." Journal of the American Academy of Dermatology 73, no. 5 (2015): S66—S69. http://dx.doi.org/10.1016/j.jaad.2015.07.040.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
32

Murphy, Bryan, Graham Morrison, and Pat Podmore. "Successful use of adalimumab to treat pyoderma gangrenosum, acne and suppurative hidradenitis (PASH syndrome) following colectomy in ulcerative colitis." International Journal of Colorectal Disease 30, no. 8 (2015): 1139–40. http://dx.doi.org/10.1007/s00384-014-2110-9.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
33

Hayden, Melvin R. "Hypothesis: Neuroglia Activation Due to Increased Peripheral and CNS Proinflammatory Cytokines/Chemokines with Neuroinflammation May Result in Long COVID." Neuroglia 2, no. 1 (2021): 7–35. http://dx.doi.org/10.3390/neuroglia2010004.

Texte intégral
Résumé :
The COVID-19 pandemic has paralleled the great Spanish flu pandemic of 1918–1919 in the United States. Previous historical accounts have strongly suggested a post-viral syndrome and, currently, a post-COVID-19 viral syndrome is unquestionable, which shares many of the characteristics of myalgic encephalomyelitis/chronic fatigue syndrome that is present globally. The original term for this post-acute sequela of SARS-CoV-2 (PASC) was termed long haulers by those who were affected with this syndrome and it is now termed long COVID (LC) or PASC. International researchers and clinicians are despera
Styles APA, Harvard, Vancouver, ISO, etc.
34

Chung, Tae Hwan, and Antoine Azar. "Autonomic Nerve Involvement in Post-Acute Sequelae of SARS-CoV-2 Syndrome (PASC)." Journal of Clinical Medicine 12, no. 1 (2022): 73. http://dx.doi.org/10.3390/jcm12010073.

Texte intégral
Résumé :
The novel SARS-CoV-2 virus and resulting COVID-19 global pandemic emerged in 2019 and continues into 2022. While mortality from COVID-19 is slowly declining, a subset of patients have developed chronic, debilitating symptoms following complete recovery from acute infection with COVID-19. Termed as post-acute sequelae of SARS-CoV-2 syndrome (PASC), the underlying pathophysiology of PASC is still not well understood. Given the similarity between the clinical phenotypes of PASC and postural orthostatic tachycardia syndrome (POTS), it has been postulated that dysautonomia may play a role in the pa
Styles APA, Harvard, Vancouver, ISO, etc.
35

Bisaccia, Giandomenico, Fabrizio Ricci, Vittoria Recce, et al. "Post-Acute Sequelae of COVID-19 and Cardiovascular Autonomic Dysfunction: What Do We Know?" Journal of Cardiovascular Development and Disease 8, no. 11 (2021): 156. http://dx.doi.org/10.3390/jcdd8110156.

Texte intégral
Résumé :
Post-acute sequelae of SARS-CoV-2 (PASC), or long COVID syndrome, is emerging as a major health issue in patients with previous SARS-CoV-2 infection. Symptoms commonly experienced by patients include fatigue, palpitations, chest pain, dyspnea, reduced exercise tolerance, and “brain fog”. Additionally, symptoms of orthostatic intolerance and syncope suggest the involvement of the autonomic nervous system. Signs of cardiovascular autonomic dysfunction appear to be common in PASC and are similar to those observed in postural orthostatic tachycardia syndrome and inappropriate sinus tachycardia. In
Styles APA, Harvard, Vancouver, ISO, etc.
36

Cugno, Massimo, Alessandro Borghi, and Angelo V. Marzano. "PAPA, PASH and PAPASH Syndromes: Pathophysiology, Presentation and Treatment." American Journal of Clinical Dermatology 18, no. 4 (2017): 555–62. http://dx.doi.org/10.1007/s40257-017-0265-1.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
37

Cavigli, Luna, Chiara Fusi, Marta Focardi, et al. "Post-Acute Sequelae of COVID-19: The Potential Role of Exercise Therapy in Treating Patients and Athletes Returning to Play." Journal of Clinical Medicine 12, no. 1 (2022): 288. http://dx.doi.org/10.3390/jcm12010288.

Texte intégral
Résumé :
Post-acute sequelae of coronavirus disease 19 (COVID-19) (PASC) describe a wide range of symptoms and signs involving multiple organ systems occurring after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, representing a growing health problem also in the world of sport and the athletic population. Patients with PASC have new, returning, or persisting symptoms four or more weeks after the infection. Among the most frequent symptoms, patients complain of fatigue, dyspnea, exercise intolerance, and reduced functional capacity that interfere with everyday life activity. The
Styles APA, Harvard, Vancouver, ISO, etc.
38

Paul, Bindu D., Marian D. Lemle, Anthony L. Komaroff, and Solomon H. Snyder. "Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome." Proceedings of the National Academy of Sciences 118, no. 34 (2021): e2024358118. http://dx.doi.org/10.1073/pnas.2024358118.

Texte intégral
Résumé :
Although most patients recover from acute COVID-19, some experience postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection (PASC). One subgroup of PASC is a syndrome called “long COVID-19,” reminiscent of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). ME/CFS is a debilitating condition, often triggered by viral and bacterial infections, leading to years-long debilitating symptoms including profound fatigue, postexertional malaise, unrefreshing sleep, cognitive deficits, and orthostatic intolerance. Some are skeptical that either ME/CFS or long COVID-19 in
Styles APA, Harvard, Vancouver, ISO, etc.
39

Challamel, Chloé, Céline Girard, Laurent Misery, et al. "Efficacité des anti-IL1 dans les syndromes PAPA et le PASH." Annales de Dermatologie et de Vénéréologie - FMC 1, no. 8 (2021): A261. http://dx.doi.org/10.1016/j.fander.2021.09.251.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
40

Fritsche, Lars G., Weijia Jin, Andrew J. Admon, and Bhramar Mukherjee. "Characterizing and Predicting Post-Acute Sequelae of SARS CoV-2 Infection (PASC) in a Large Academic Medical Center in the US." Journal of Clinical Medicine 12, no. 4 (2023): 1328. http://dx.doi.org/10.3390/jcm12041328.

Texte intégral
Résumé :
Background: A growing number of Coronavirus Disease-2019 (COVID-19) survivors are affected by post-acute sequelae of SARS CoV-2 infection (PACS). Using electronic health record data, we aimed to characterize PASC-associated diagnoses and develop risk prediction models. Methods: In our cohort of 63,675 patients with a history of COVID-19, 1724 (2.7%) had a recorded PASC diagnosis. We used a case–control study design and phenome-wide scans to characterize PASC-associated phenotypes of the pre-, acute-, and post-COVID-19 periods. We also integrated PASC-associated phenotypes into phenotype risk s
Styles APA, Harvard, Vancouver, ISO, etc.
41

Mylvaganam, Ruben J., Joseph I. Bailey, Jacob I. Sznajder, and Marc A. Sala. "Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection." European Respiratory Review 30, no. 162 (2021): 210194. http://dx.doi.org/10.1183/16000617.0194-2021.

Texte intégral
Résumé :
Acute manifestations of SARS-CoV-2 infection continue to impact the lives of many across the world. Post-acute sequelae of coronavirus disease 2019 (COVID-19) may affect 10–30% of survivors of COVID-19, and post-acute sequelae of COVID-19 (PASC)-pulmonary fibrosis is a long-term outcome associated with major morbidity. Data from prior coronavirus outbreaks (severe acute respiratory syndrome and Middle East respiratory syndrome) suggest that pulmonary fibrosis will contribute to long-term respiratory morbidity, suggesting that PASC-pulmonary fibrosis should be thoroughly screened for through pu
Styles APA, Harvard, Vancouver, ISO, etc.
42

Taylor, David C., Anthony J. Salvian, and Christopher R. Shackleton. "Crush syndrome complicating pneumatic antishock garment (PASG) use." Injury 19, no. 1 (1988): 43–44. http://dx.doi.org/10.1016/0020-1383(88)90178-7.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
43

Meyer, Albin, Benjamin Alric, Olivier Dézerald, et al. "Linking Micropollutants to Trait Syndromes across Freshwater Diatom, Macroinvertebrate, and Fish Assemblages." Water 14, no. 8 (2022): 1184. http://dx.doi.org/10.3390/w14081184.

Texte intégral
Résumé :
The ecological quality of freshwater ecosystems is endangered by various micropollutants released into the environment by human activities. The cumulative effects of these micropollutants can affect the fitness of organisms and populations and the functional diversity of stream ecosystems. In this study, we investigated the relationships between the joint toxicity of micropollutants and trait syndromes. A trait syndrome corresponds to a combination of traits that could occur together in communities due to the trait selection driven by exposure to these micropollutants. Our objectives were to (
Styles APA, Harvard, Vancouver, ISO, etc.
44

Graille, J., M. Beylot-Barry, O. Cogrel, A. Fauconneau, and M. S. Doutre. "PAPA, PASH, PAPASH, PsAPASH, PASS… des syndromes auto-inflammatoires PAS si simples." La Revue de Médecine Interne 36 (December 2015): A205—A206. http://dx.doi.org/10.1016/j.revmed.2015.10.218.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
45

Jason, Leonard A., and Mohammed F. Islam. "A CLASSIFICATION SYSTEM FOR POST-ACUTE SEQUELAE OF SARS CoV-2 INFECTION." Central Asian Journal of Medical Hypotheses and Ethics 3, no. 1 (2022): 38–51. http://dx.doi.org/10.47316/cajmhe.2022.3.1.04.

Texte intégral
Résumé :
This study aimed to contribute to the development of a research case definition for post-acute sequelae of SARS CoV-2 infection (PASC) using a PASC data set and experiences from case definitions developed for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Our database included patients with PASC who provided self-report symptomology during the onset of infection and the time of survey completion (post-infection). We found that we could distinguish between those with mild, moderate, and severe PASC. Regarding the proportion meeting an ME/CFS case definition, we found 0% in the mil
Styles APA, Harvard, Vancouver, ISO, etc.
46

Kell, Douglas B., Gert Jacobus Laubscher, and Etheresia Pretorius. "A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications." Biochemical Journal 479, no. 4 (2022): 537–59. http://dx.doi.org/10.1042/bcj20220016.

Texte intégral
Résumé :
Post-acute sequelae of COVID (PASC), usually referred to as ‘Long COVID’ (a phenotype of COVID-19), is a relatively frequent consequence of SARS-CoV-2 infection, in which symptoms such as breathlessness, fatigue, ‘brain fog’, tissue damage, inflammation, and coagulopathies (dysfunctions of the blood coagulation system) persist long after the initial infection. It bears similarities to other post-viral syndromes, and to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Many regulatory health bodies still do not recognize this syndrome as a separate disease entity, and refer to it und
Styles APA, Harvard, Vancouver, ISO, etc.
47

Ravaglia, Fabio F. A., M. Goretti Leite, Tiago F. Bracellos, and Alberto Cliquet. "Postambulatory Hand Swelling (Big Hand Syndrome): Prevalence, Demographics, and Association with Dog Walking." ISRN Rheumatology 2011 (December 6, 2011): 1–4. http://dx.doi.org/10.5402/2011/659695.

Texte intégral
Résumé :
Introduction. Postambulatory hand swelling (PAHS) seems to be common in the general population. There are few mention in the medical literature. The objective were (1) to identify prevalence; (2) to compare gender and age groups; (3) to determine if dog owners and walkers are more or less prone. Materials and Methods. 1009 semirandomly surveys were completed from walkers. Age, gender, and dog ownership were assessed. We discussed, among dog owners, whether or not they walk their dog regularly, whether or not they notice swollen hands after walking, and, if so, if the swelling resolves over 24
Styles APA, Harvard, Vancouver, ISO, etc.
48

Marks, David F. "Converging Evidence of Similar Symptomatology of ME/CFS and PASC Indicating Multisystemic Dyshomeostasis." Biomedicines 11, no. 1 (2023): 180. http://dx.doi.org/10.3390/biomedicines11010180.

Texte intégral
Résumé :
The purpose of this article is to review the evidence of similar symptomatology of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and post-acute sequelae of SARS-CoV-2 infection (PASC). Reanalysis of data from a study by Jason comparing symptom reports from two groups of ME/CFS and PASC patients shows a notably similar symptomatology. Symptom scores of the PASC group and the ME/CFS group correlated 0.902 (p < 0.0001) across items. The hypothesis is presented that ME/CFS and PASC are caused by a chronic state of multisystemic disequilibrium including endocrinological, immunologi
Styles APA, Harvard, Vancouver, ISO, etc.
49

Malarvizhi D and Hariharan S. "Correlation of Hand Grip, Gait Speed, Physical Activity with Frailty Index in Geriatric Population." International Journal of Research in Pharmaceutical Sciences 12, no. 1 (2021): 208–12. http://dx.doi.org/10.26452/ijrps.v12i1.3980.

Texte intégral
Résumé :
The Geriatric syndrome includes a series of representation which may be related to ageing such as delirium, falls, incontinence and frailty. Frailty is a common clinical syndrome in geriatric population that supports the weight of enhancing the risk of poor health outcomes, including the falls incident, disability, hospitalization and mortality. This study aims to find out the Correlation of Hand Grip, Gait Speed and Physical Activity with Frailty Index in Geriatric Population. It is an observational study done with convenient sampling with 40 participants of both the sexes were selected based
Styles APA, Harvard, Vancouver, ISO, etc.
50

Cerretelli, Guia, Ann Ager, Mark J. Arends, and Ian M. Frayling. "Molecular pathology of Lynch syndrome." Journal of Pathology 250, no. 5 (2020): 518–31. http://dx.doi.org/10.1002/path.5422.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
Nous offrons des réductions sur tous les plans premium pour les auteurs dont les œuvres sont incluses dans des sélections littéraires thématiques. Contactez-nous pour obtenir un code promo unique!